XML 18 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Shareholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Common Stock
Unrecognized Gains (Losses) on Derivative Instruments
Pension Obligations
Cumulative Translation Adjustment
Retained Earnings
Beginning of period at Dec. 31, 2020 $ (21,522) $ 95,247 $ (1,738) $ (7,447) $ (90,261) $ (17,323)
Beginning of the period (in shares) at Dec. 31, 2020   25,591,930        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 7,637         7,637
Change in unrecognized gains (losses) on derivative instruments, net of tax 101   101      
Change in defined benefit plans, net of tax 290     290    
Net foreign currency translation adjustment (16,336)       (16,336)  
Common stock issued, net of shares withheld for employee taxes (in shares)   556,867        
Stock-based compensation 5,371 $ 5,371        
Redeemable preferred 9% dividend and accretion (25,310)         (25,310)
European non-controlling redeemable equity dividend (134)         (134)
End of period at Sep. 30, 2021 (49,903) $ 100,618 (1,637) (7,157) (106,597) (35,130)
End of the period (in shares) at Sep. 30, 2021   26,148,797        
Beginning of period at Jun. 30, 2021 (20,555) $ 98,236 5,247 (7,253) (97,529) (19,256)
Beginning of the period (in shares) at Jun. 30, 2021   26,107,462        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (7,180)         (7,180)
Change in unrecognized gains (losses) on derivative instruments, net of tax (6,884)   (6,884)      
Change in defined benefit plans, net of tax 96     96    
Net foreign currency translation adjustment (9,068)       (9,068)  
Common stock issued, net of shares withheld for employee taxes (in shares)   41,335        
Stock-based compensation 2,382 $ 2,382        
Redeemable preferred 9% dividend and accretion (8,598)         (8,598)
European non-controlling redeemable equity dividend (96)         (96)
End of period at Sep. 30, 2021 (49,903) $ 100,618 (1,637) (7,157) (106,597) (35,130)
End of the period (in shares) at Sep. 30, 2021   26,148,797        
Beginning of period at Dec. 31, 2021 $ (70,421) $ 103,214 (9,051) (6,133) (110,790) (47,661)
Beginning of the period (in shares) at Dec. 31, 2021 26,163,077 26,163,077        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) $ 20,563         20,563
Change in unrecognized gains (losses) on derivative instruments, net of tax 8,329   8,329      
Change in defined benefit plans, net of tax 249     249    
Net foreign currency translation adjustment (17,946)       (17,946)  
Common stock issued, net of shares withheld for employee taxes (in shares)   853,048        
Stock-based compensation 4,754 $ 4,754        
Redeemable preferred 9% dividend and accretion (27,103)         (27,103)
European non-controlling redeemable equity dividend (42)         (42)
End of period at Sep. 30, 2022 $ (81,617) $ 107,968 (722) (5,884) (128,736) (54,243)
End of the period (in shares) at Sep. 30, 2022 27,016,125 27,016,125        
Beginning of period at Jun. 30, 2022 $ (72,783) $ 106,078 (7,813) (5,967) (120,401) (44,680)
Beginning of the period (in shares) at Jun. 30, 2022   27,016,125        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (351)         (351)
Change in unrecognized gains (losses) on derivative instruments, net of tax 7,091   7,091      
Change in defined benefit plans, net of tax 83     83    
Net foreign currency translation adjustment (8,335)       (8,335)  
Stock-based compensation 1,890 $ 1,890        
Redeemable preferred 9% dividend and accretion (9,192)         (9,192)
European non-controlling redeemable equity dividend (20)         (20)
End of period at Sep. 30, 2022 $ (81,617) $ 107,968 $ (722) $ (5,884) $ (128,736) $ (54,243)
End of the period (in shares) at Sep. 30, 2022 27,016,125 27,016,125